Groundbreaking Pre-Eclampsia Screening Test to Be Trialled
July 25, 2024
July 25, 2024
MANCHESTER, England, July 25 (TNSres) -- The University of Manchester issued the following news release:
Researchers are to trial a ground-breaking screening test for pre-eclampsia, a potentially life-threatening condition affecting pregnant women and their unborn babies.
The Screen and Treat with Aspirin to Reduce Pre-eclampsia (STARshiP) study is led by researchers from Saint Mary's Managed Clinical Service, part of Manchester University NHS Foundation Trust (MFT), in . . .
Researchers are to trial a ground-breaking screening test for pre-eclampsia, a potentially life-threatening condition affecting pregnant women and their unborn babies.
The Screen and Treat with Aspirin to Reduce Pre-eclampsia (STARshiP) study is led by researchers from Saint Mary's Managed Clinical Service, part of Manchester University NHS Foundation Trust (MFT), in . . .